Burning Rock Biotech Limited Cash and Restricted Cash
Burning Rock Biotech Limited (BNR) had Cash and Restricted Cash of CNY 481.09 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-04-28
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 481.09M CNY.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 522.16M CNY.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 615.22M CNY.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 925.27M CNY.
CNY
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | 481.09M CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 522.16M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 615.22M CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 925.27M CNY 20-F · filed 2026-04-28 |
| 2022-06-30 | 1.15B CNY 6-K · filed 2022-11-07 |
| 2021-12-31 | 1.44B CNY 20-F · filed 2025-04-29 |
| 2021-06-30 | 1.88B CNY 6-K · filed 2022-11-07 |
| 2020-12-31 | 1.93B CNY 20-F · filed 2024-04-29 |
| 2019-12-31 | 98.24M CNY 20-F · filed 2023-04-20 |
| 2018-12-31 | 95.33M CNY 20-F · filed 2022-04-29 |
| 2017-12-31 | 54.79M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $68.80M 20-F · filed 2026-04-28 | |
| 2024-12-31 | $74.67M 20-F · filed 2026-04-28 | $71.54M 20-F · filed 2025-04-29 |
| 2023-12-31 | $84.28M 20-F · filed 2025-04-29 | $86.65M 20-F · filed 2024-04-29 |
| 2022-12-31 | $130.32M 20-F · filed 2024-04-29 | $134.15M 20-F · filed 2023-04-20 |
| 2022-06-30 | $172.15M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $208.65M 20-F · filed 2023-04-20 | $225.83M 20-F · filed 2022-04-29 |
| 2020-12-31 | $302.11M 20-F · filed 2022-04-29 | $295.05M 20-F · filed 2021-03-23 |
| 2019-12-31 | $15.06M 20-F · filed 2021-03-23 |